STOCK TITAN

Tilt Hldgs Inc Stock Price, News & Analysis

TLLTF OTC

Welcome to our dedicated page for Tilt Hldgs news (Ticker: TLLTF), a resource for investors and traders seeking the latest updates and insights on Tilt Hldgs stock.

TILT Holdings Inc. (TLLTF) generates a wide range of company news tied to its role as a global provider of cannabis business solutions. Its disclosures describe a portfolio that includes inhalation technologies, cultivation, manufacturing, processing, brand development and retail, with a core focus on Jupiter Research LLC, a wholly owned subsidiary active in vaporization hardware design, research, development, manufacturing and distribution. News about TILT often highlights how these activities support cannabis brands and retailers across North America, South America, Israel and the European Union.

Recent announcements show that TILT’s news flow covers both operational performance and strategic restructuring. Earnings releases discuss quarterly financial and operating results, including revenue trends, gross margin dynamics and the impact of strategic shifts such as divesting plant-touching assets in Massachusetts and Ohio or transitioning parts of Jupiter’s business to a commission-based model. Operational updates also describe regulatory approvals, such as European Union medical device certification for a handheld liquid inhalation device developed by Jupiter, and agreements with partners like Curaleaf International for commercialization in medical markets.

Another important stream of news relates to capital structure and creditor arrangements. TILT has reported entering into secured note purchase agreements for bridge financing, receiving default notices from landlords on certain cultivation properties, and negotiating forbearance arrangements. The company has also issued multiple releases about its CCAA restructuring process in the Supreme Court of British Columbia, including the initial order granting creditor protection, the proposed plan of arrangement to take the company private, and notices of meetings for noteholders.

For users following TLLTF on this news page, the coverage provides a consolidated view of TILT’s financial results, restructuring milestones, asset sales, regulatory certifications and governance events such as shareholder meeting outcomes. Investors and observers can use this archive to trace how TILT’s strategy has evolved toward Jupiter-centered, asset-light operations and to understand the context behind its delisting and restructuring decisions.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
21.64%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.3%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.91%
Tags
none
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-12.24%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.58%
Tags
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.54%
Tags
partnership
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.26%
Tags
conferences earnings
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.36%
Tags
none
-
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.48%
Tags
management
Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.7%
Tags
conferences

FAQ

What is the current stock price of Tilt Hldgs (TLLTF)?

The current stock price of Tilt Hldgs (TLLTF) is $0.000001 as of March 2, 2026.

What is the market cap of Tilt Hldgs (TLLTF)?

The market cap of Tilt Hldgs (TLLTF) is approximately 2.7M.

TLLTF Rankings

TLLTF Stock Data

2.69M
322.44M
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Phoenix

TLLTF RSS Feed